Outcome of high-power short-duration radiofrequency ablation in combination with half-normal saline irrigation for the treatment of atrial fibrillation

被引:3
|
作者
Maan, Abhishek [1 ]
Bode, Weeranun D. [1 ]
Heist, E. Kevin [1 ]
Ha, Grace [1 ]
Carnicelli, Anthony [3 ]
Slattery, Kathryn [2 ]
Fitzsimons, Michael [2 ]
Ruskin, Jeremy [1 ]
Mansour, Moussa [1 ]
机构
[1] Massachusetts Gen Hosp, Heart Ctr, Cardiac Arrhythmia Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA
[3] Duke Univ Hosp, Duke Clin Res Inst, Durham, NC USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2022年 / 45卷 / 01期
关键词
half-normal saline; high power; radiofrequency ablation; short duration; PULMONARY VEIN ISOLATION; CATHETER ABLATION; LESION FORMATION; CONTACT FORCE; PERSISTENT; MULTICENTER; IMPEDANCE; TRIGGERS; TEMPERATURE; ELECTRODE;
D O I
10.1111/pace.14407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Data regarding the use of high-power short-duration (HPSD) radiofrequency (RF) in combination with half-normal saline irrigation for catheter irrigation are limited. Objectives This study investigated the safety and efficacy of using HPSD RF ablation in combination with half-normal saline irrigation for the treatment of AF. Methods One hundred consecutive patients with AF underwent RF ablation using HPSD combined with half-normal saline for catheter irrigation. In addition, the following ablation strategies were used: 1 mm tags for the display of ablation lesions on the mapping system, high-frequency jet ventilation (HFJV), low contact force, pacing after ablation to verify areas of noncapture, atrial/ventricular pacing at 500 to 700 ms to aid in catheter stability, use of two skin electrodes to reduce impedance, and postablation adenosine infusion. Power was started at 40 to 45 W and was modulated manually based on impedance changes. Results The average age of patients was 65.2 years and 70% were male. Forty seven percent had paroxysmal AF and the average CHA(2)DS(2)-VASc score was 2.1 +/- 1.6. The average power and lesion duration were 38.1 +/- 3.3 W and 8.1 +/- 2.3 s, respectively. During a median follow-up period of 321 +/- 139 days, 89% of the patients remained free from any atrial arrhythmias after a single RF ablation procedure. No procedure-related death, stroke, pericardial effusion, or atrioesophageal fistula occurred during follow-up. Conclusions Catheter ablation using HPSD RF lesions in combination with half-normal saline irrigation and is safe and effective, and results in high rate of freedom from AF.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [21] Very high-power and short-duration radiofrequency ablation for atrial fibrillation in a Latin American low-volume private center
    Keegan, Roberto
    Garmendia, Francisco
    Gregorietti, Franco
    Urruti, Ricardo
    Onetto, Leonardo
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2024, 67 (6) : 1399 - 1406
  • [22] Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation
    Khanra, Dibbendhu
    Hamid, Abdul
    Deshpande, Saurabh
    Mukherjee, Anindya
    Petkar, Sanjiv
    Saeed, Mohammad
    Basu-Ray, Indranill
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 (01) : 2 - +
  • [23] One-year outcomes in patients undergoing very high-power short-duration ablation for atrial fibrillation
    Francesco Solimene
    Teresa Strisciuglio
    Vincenzo Schillaci
    Alberto Arestia
    Gergana Shopova
    Armando Salito
    Giuseppe Bottaro
    Giovanni Marano
    Fernando Coltorti
    Giuseppe Stabile
    Journal of Interventional Cardiac Electrophysiology, 2023, 66 : 1911 - 1917
  • [24] Comparison of very high-power short-duration, high-power short-duration, and low-power long-duration radiofrequency ablation for atrial fibrillation: A systematic review and network meta-analysis
    Junarta, Joey
    Rodriguez, Sebastian
    Ullah, Waqas
    Siddiqui, Muhammad U.
    Riley, Joshua M.
    Patel, Anjani
    O'Neill, Parker
    Dikdan, Sean J.
    Fradin, James J.
    Rosen, Jake L.
    Frisch, Daniel R.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (12): : 1609 - 1634
  • [25] One-year outcomes in patients undergoing very high-power short-duration ablation for atrial fibrillation
    Solimene, Francesco
    Strisciuglio, Teresa
    Schillaci, Vincenzo
    Arestia, Alberto
    Shopova, Gergana
    Salito, Armando
    Bottaro, Giuseppe
    Marano, Giovanni
    Coltorti, Fernando
    Stabile, Giuseppe
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2023, 66 (08) : 1911 - 1917
  • [26] Safe and effective delivery of high-power, short-duration radiofrequency ablation lesions with a flexible-tip ablation catheter
    Ptaszek, Leon M.
    Koruth, Jacob
    Santangeli, Pasquale
    Piccini, Jonathan P.
    Ranjan, Ravi
    Mahapatra, Srijoy
    Pipenhagen, Catherine
    Fish, Jeffrey M.
    Moon, L. Boyce
    Ambrosius, Nicholas M.
    Boudlali, Hana
    Jensen, James A.
    HEART RHYTHM O2, 2023, 4 (01): : 42 - 50
  • [27] The efficacy of high-power short-duration radiofrequency for atrial fibrillation ablation A protocol for systematic review and meta-analysis
    Zhang, Peng
    Ma, Ling
    Wang, Fei
    Shi, Liang
    MEDICINE, 2021, 100 (16) : E25569
  • [28] Massive pleural effusion following high-power and short-duration radiofrequency ablation for treatment of atrial fibrillation: A case report and review of the literature
    He, Miaomiao
    Qiu, Jie
    Bai, Yang
    Wang, Yan
    Chen, Guangzhi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [29] Revisiting symptomatic pulmonary vein stenosis after high-power short-duration radiofrequency ablation in patients with atrial fibrillation
    Kim, Joongmin
    Kim, Daehoon
    Yu, Hee Tae
    Kim, Tae-Hoon
    Joung, Boyoung
    Lee, Moon-Hyoung
    Pak, Hui-Nam
    EUROPACE, 2023, 25 (10):
  • [30] High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation
    Junarta, Joey
    Dikdan, Sean J.
    Upadhyay, Naman
    Bodempudi, Sairamya
    Shvili, Michael Y.
    Frisch, Daniel R.
    HEART AND VESSELS, 2022, 37 (06) : 1003 - 1009